Related Experiment Videos
[Vector electrocardiographic features in patients with hypertrophic cardiomyopathy]
Insights
Electrocardiography can detect myocardial scarring in hypertrophic cardiomyopathy (HCM) and coronary heart disease (CHD). Specific wave patterns help differentiate these conditions when Q and QS waves are present.
Area of Science:
- Cardiology
- Medical Imaging
- Diagnostic Electrocardiography
Background:
- Abnormal Q and QS waves on electrocardiograms (ECG) can indicate myocardial scarring.
- Distinguishing between hypertrophic cardiomyopathy (HCM) and coronary heart disease (CHD) using ECG findings, particularly Q/QS waves, is clinically significant.
- Previous ECG analyses have shown limitations in differentiating HCM from CHD based solely on Q/QS wave presence.
Purpose of the Study:
- To identify specific electrocardiographic (ECG) criteria for differentiating hypertrophic cardiomyopathy (HCM) from coronary heart disease (CHD) in the presence of abnormal Q and QS waves.
- To evaluate the utility of quantitative ECG parameters in distinguishing myocardial scarring sites between HCM and CHD.
- To determine if specific ECG sign complexes can reliably differentiate HCM and CHD when Q and QS waves are observed.
Main Methods:
- Analysis of abnormal Q and QS waves using an adjusted lead system (Z and Y leads).
- Quantitative assessment of specific ECG wave characteristics (Rx, Sy, Rxyz, Sxyz, Sz).
- Identification of characteristic sign complexes associated with anterior and inferior myocardial scarring in HCM and CHD.
Main Results:
- Abnormal Q and QS waves in Z and Y leads clearly reflect the predominant site of myocardial scarring in both HCM and CHD (anteriorly in Z, inferiorly in Y).
- Quantitative differences in Q/QS waves alone were insufficient for electrocardiographic differentiation between HCM and CHD.
- A specific complex of ECG signs was identified: elevated Rx, Sy, and Rxyz+Sxyz for anterior scarring, and increased Sz and Sxyz for inferior scarring, aiding differentiation.
- In CHD patients with myocardial scarring and arterial hypertension, only indirect ECG signs were observed.
Conclusions:
- Specific quantitative ECG criteria, beyond simple Q/QS wave presence, are necessary to differentiate HCM from CHD.
- The identified ECG sign complexes provide a more reliable method for distinguishing myocardial scarring locations and potentially differentiating between HCM and CHD.
- Further investigation into indirect ECG signs in CHD with co-existing hypertension and scarring may be warranted.
Abstract:
The examination indicated that abnormal Q and QS waves recorded along the azes Z and Y in the adjusted lead system far clearly reflected a predominant site of suspected focal and scarring lestoh in hypertrophic cardiomyopathy (HCM) as in coronary heart disease (CHD) (the anterior site in the Z lead and inferior one, in the Y lead), however, the difference in their quantitative characteristics do not fulfil the goals of the electrocardiographic differentiation between HCM and CHD. To differentiate HCM and CHD in the presence of Q and QS waves, a characteristic complex of signs was identified: elevated waves Rx (greater than or equal to 17.5 mm), Sy (greater than or equal to 7.3 mm) of the total value, sigma Rxyz + sigma Sxyz (greater than or equal to 48.3 mm) at the anterior site of "scarring" myocardial lesion and increased waves Sz (greater than or equal to 20.4 mm), sigma Sxyz (greater than or equal to 21.4 mm) at the inferior site. Only "indirect" signs remained on VECG in the presence of scarring myocardial lesion concurrent with arterial hypertension in CHD patients.